Introduction
Acute viral hepatitis A is widely prevalent in India. 1 Viral hepatitis is the leading of acute hepatitis in children in our country, and hepatitis A is the most common type of viral hepatitis. Hepatitis A does not commonly present with severe anemia unless it is complicated by fulminant hepatic failure (FHF) and significant blood loss. However, in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common inherited enzyme deficiency worldwide, 2 hepatitis A may cause severe anemia in absence of major blood loss. This chance association has been reported earlier by Sarkar et al. 3 The coincidence of acute hepatitis A and G6PD deficiency may cause acute intravascular hemolysis, manifest as pallor, icterus, hepatosplenomegaly, and dark-colored urine. The pathogenetic mechanism of hemolytic anemia in hepatitis A infection is ill-understood, but it has been reported to be autoimmune mediated in at least some cases. 4, 5 Here, we report a case of acute hepatitis A complicated by FHF and acute intravascular hemolysis associated with G6PD deficiency.
Case Report
A 7-year-old male child born to a nonconsanguineous parent presented with moderate grade fever, yellowish discoloration of eyes, and urine for the past 5 days before admission. There was no history of hematemesis, melena, or any other bleeding, swelling of body, convulsion, and drug ingestion just before present illness or any previous blood transfusion. His urine volume was satisfactory. On examination, the child was deeply icteric, severely anemic, and drowsy. Abdominal examination revealed soft hepatomegaly of 6.5 cm below right costal arch on right midclavicular line and enlarged spleen of approximately 3 cm below the left costal arch. There was no ascites. Except for drowsiness he had no neurological deficit; his plantar reflexes were flexor. Slit lamp examination of the eye did not reveal Keyser-Fleischer rings. On the day following admission, his urine color changed to dark brown or blackish.
Laboratory testing on admission showed a normocytic, normochromic anemia (hemoglobin 4.5 g/dL), reticulocyte count 14.1%, and total leukocyte count 20,000/mm 3 (neutrophils 80%, lymphocytes 17%, monocytes 2%, and eosinophils 1%). The platelet count was 350 Â 10 9 /L. Prothrombin time was 15.9 seconds (control, 10.2 seconds), giving an international normalized ratio of 1.3 (normal, 1-1.2), and activated partial thromboplastin time was 23.5 seconds (normal, 22.6-35 seconds). The total serum bilirubin was 61.2 mg/dL (conjugated, 32.9 mg/dL; unconjugated, 28.3 mg/dL); serum total protein was 5.9 g/dL, and albumin and globulin were 3.6 and 2.3 g/dL, respectively, giving a albumin:globulin ratio of
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1.57:1 (normal, 2:1). Liver enzymes were elevated as follows: aspartate aminotransferase 1,474 U/L (normal, 0-40 U/L), alanine aminotransferase 680 U/L (normal, 0-41 U/L) and alkaline phosphatase 354 U/L (normal, 100-250 U/L). Hepatitis A-specific IgM antibodies were detected in serum; serological tests for hepatitis B, C, and E were negative. The results of Coombs direct and indirect antiglobulin tests were negative. Serum ceruloplasmin was 42.5 mg/dL (normal, 20-40 mg/dL), and urinary copper excretion was 45 µg during a 24-hour period (normal, 4-60 µg). Challenge with two doses of penicillamine increased the 24-hour urine copper excretion to 150 µg. Urinalysis showed hemoglobinuria without erythrocytes. Tests for antinuclear antibody and antismooth muscle antibody were negative. Using the scoring system of the International Autoimmune Hepatitis Group the objective score was < 10. A peripheral blood smear was negative for malaria, and a dual malaria antigen test was also negative. G6PD assay showed a level of enzymatic activity of 4.7 U/g Hb (normal, 4.6-3.5 U/g).
The child was managed with intravenous fluid and mannitol to maintain his fluid-electrolyte balance. Cefotaxime was commenced empirically in case bacterial sepsis was the cause of initial presentation; this was continued to protect the child from developing sepsis, which is a common complication of FHF. The child was transfused 1 unit of concentrated RBCs. After 48 hours, he regained full consciousness, and after 3 to 4 days the urine discoloration improved. Two months later at outpatient follow-up, the patient had hepatomegaly of 2.5 cm below right costal arch, but no splenomegaly, anemia, or jaundice. Liver function test results had normalized; G6PD enzymatic activity was 1.30 U/g Hb.
Discussion
Hepatitis A virus infection is usually considered to be a mild disease, although severe, even fatal, cases can occur. 6 In particular, G6PD deficient children are at risk of FHF, renal failure, hemolytic anemia, and severe hyperbilirubinemia. 7 Acute hepatitis E infection with coexistent G6PD deficiency leading to acute hemoglobinuria without acute renal failure has also been reported. 8 Likewise, hepatitis D superinfection in a chronic HBSAg carrier with G6PD deficiency has been associated with acute hemoglobinuria. 9 Severe anemia without major blood loss is an unusual feature of hepatitis A infection. In our case, the urine became blackish, rather than demonstrating the classic mustard oil color of bilirubinuria. The presence of severe anemia together with the urine appearance, severe jaundice, and splenomegaly made us suspect intravascular hemolysis. Acute hemoglobinuria is usually associated with only a few conditions, for example, mismatched blood transfusion, snake bite, G6PD deficiency, black water fever hemolytic uremic syndrome, autoimmune hemolytic anemia (especially an acute variety that occurs in children), Wilson disease. Black water fever was ruled out in this case. The G6PD enzyme level was low-normal during acute phase of our case, but it was found to be grossly reduced when retested during convalescence. This can occur because during an episode of acute hemolysis, peripheral blood con-tains an excess of young red cells that contain higher amounts of the G6PD enzyme. G6PD-deficient individuals usually appear clinically normal; however, acute hemoglobinuria can be precipitated by bacterial and viral infections, or by drugs, for example, primaquine, vitamin K, sulfonamides, nalidixic acid. In our case, acute hepatitis A infection was the precipitating factor. Earlier Hosnut et al 10 reported hemolysis in hepatitis A infection because of the autoimmune hemolytic anemia and G6PD deficiency, but in their case, administration of vitamin K was considered to have been a contributory factor.
Autoimmune hemolytic anemia was excluded in our case on the basis of negative autoimmune antibody and direct and indirect Coombs test results. Autoimmune hepatitis was ruled out by negative serological studies and by application of an objective scoring system. Despite acute hemoglobinuria, this patient did not develop acute renal failure, contrary to previous reports. 7, 8 G6PD catalyses the initial step in the hexose monophosphate shunt, oxidizing glucose-6-phosphate to 6-phosphogluconolactone, and reducing NADP to NADPH. The hexose monophosphate shunt pathway of glucose metabolism is the only red cell source of NADPH. NADPH acts as a cofactor for conversion of glutathione to reduced glutathione, which is essential to metabolize oxidant products within RBC. Thus, in the absence of reduced glutathione, RBC is vulnerable to hemolysis.
In conclusion, it is suggested that all patients with acute viral hepatitis A, marked hyperbilirubinemia and severe pallor should be assessed for acute intravascular hemolysis and G6PD deficiency. Universal vaccination against hepatitis A, or routine newborn screening for G6PD deficiency in Asian countries like India, would help avoid hepatitis A-associated acute intravascular hemolysis. Evidence in the form of large clinical-and cost-effectiveness studies is required to support a change in national policy.
